Lyra Therapeutics, Inc.·4

May 16, 4:30 PM ET

MERRIFIELD C ANN 4

4 · Lyra Therapeutics, Inc. · Filed May 16, 2025

Insider Transaction Report

Form 4
Period: 2025-05-14
Transactions
  • Award

    Restricted Stock Units

    2025-05-14+32,00032,000 total
    Common Stock (32,000 underlying)
Footnotes (1)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% on the earlier of (i) the day before the Issuer's next annual meeting, (ii) May 14, 2026 and (iii) upon a Change in Control as defined in the 2020 Incentive Award Plan.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4